Tag: pharmaceutical policy
-
Australia Urges Pediatric ADHD Formulations to Cut Poisoning Risks
Growing Concern Over ADHD Medication Poisonings New data from Australia shows a worrying rise in poisoning incidents involving ADHD medications over the past decade. Researchers report that the number of children and adolescents harmed by misused or improper dosing has quadrupled in ten years, prompting calls for safer, age-appropriate pharmaceutical options. The push for pediatric…
-
Trump Administration Reaches Deals to Lower GLP-1 Weight Loss Drug Prices for Medicare Patients
The Trump administration announced a set of price-lowering agreements on Thursday with two of the world’s leading pharmaceutical companies, Novo Nordisk and Eli Lilly. The deals target GLP-1 receptor agonists—drugs widely prescribed for weight management and diabetes—that have faced scrutiny for their rising costs in recent years. By negotiating rebates and price caps, officials say…